FDA panel recommends Pfizer’s Covid booster doses for people 65 and older after rejecting third shots for general population
An influential Food and Drug Administration advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer and BioNTech’s Covid-19 vaccine to the general public, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans. “It’s likely beneficial, in my opinion, for the… Read More »